Database

Startups

Main Industry
Health Care
Main Product/Service
A speech biomarker–based digital platform for early cognitive screening and non-pharmaceutical stimulation in dementia prevention.
Founded Year
2024
Unified Business No.
00131702
Status
Active
Number of Employees
0
Total Paid-in Capital
1,000,000 (NT$)
Location of Company
Taiwan , Taoyuan City
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, MOE."
Introduction
KVQ Intelligence focuses on voice AI. Its product, AI-Brain Quick Screening, uses vocal biomarkers to provide a non-invasive, high-accuracy cognitive screening tool. It can be used for early dementia detection as well as non-pharmacological cognitive stimulation therapy for people with dementia. AI-Brain is the first tool on LINE for cognitive screening, the first platform to predict both CASI and MMSE scores using voice, and the fastest cognitive screening tool in the world. The web version offers predictions of seven cognitive domain scores and provides a management system for easily tracking test subject’s historical test results.



More ↓

Similar Companies

DeepRad.AI INC.

DeepLung-CAC

The product is an all-in-one screening system targeting the chest region, encompassing the lung, heart, and bone. Utilizing deep learning analysis on low-dose chest CT scans, this multi-module system is capable of automatically detecting lung nodules, predicting coronary artery calcification risk, and assessing bone density risk. As well as an auto report system that allows radiologists to preview and edit the comprehensive report. DeepBrain-Cognito

A Novel AI technology allowed researchers to capture the FUTURE 4D brain degeneration for the first time. This combo algorithms portray not only the patterns of regional brain cortical thinning in 4D but also the phenotypical behavior in standard clinical dementia rating (CDR) scores, potentially facilitating early detection of dementia in sub-healthy group, delaying the aging process, and contributing to the development of early intervention and preventive medicine.